Search

everythinglearnresearchcommunity

for

Search:↓

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Finasteride can still be used for hair loss with careful consideration of side effects and patient information.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Finasteride 1 mg may help prevent prostate issues, but more research is needed to confirm its benefits.

Adherence to finasteride treatment for prostate issues is generally low.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

Cancer development is like natural selection, involving mutated cells and environmental factors.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Finasteride effectively reduces prostate size and lowers surgery risk in men with benign prostatic hyperplasia.

BPH treatments are improving with personalized medicine and better surgical options.

Hair from breast cancer patients shows changes in structure and composition, and a test using these changes detected cancer but also falsely identified some healthy samples as cancerous.

Tumor proteins can both promote and suppress cancer, depending on the situation.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

N13-substituted evodiamine derivatives improved anticancer activity and solubility, showing promise for drug development.

Higher C-peptide levels in African-American men and higher HbA1c levels in Caucasian men are linked to lower PSA levels.

Androgen-driven traits don't predict prostate cancer recurrence.

Finasteride significantly reduces prostate cancer risk.

Finasteride may reduce prostate cancer risk.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Finasteride may improve prostate cancer treatment outcomes.

Certain Dibenzo derivatives may help treat prostate cancer.

A new compound, 3a, effectively fights prostate cancer better than finasteride.